IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
0.5682
+0.0152 (2.75%)
At close: Nov 13, 2026, 4:00 PM EST
0.5876
+0.0194 (3.41%)
After-hours: Nov 13, 2026, 7:49 PM EST
Company Description
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany.
It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands.
The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
IM Cannabis Corp.
| Country | Canada |
| Founded | 1980 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 44 |
| CEO | Oren Shuster |
Contact Details
Address: 3606 – 833 Seymour Street Vancouver, BC V6B 0G4 Canada | |
| Website | imcannabis.com |
Stock Details
| Ticker Symbol | IMCC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| CIK Code | 1792030 |
| CUSIP Number | 44969Q505 |
| ISIN Number | CA44969Q5059 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Eyal Fisher | Chief Executive Officer of the IMC Holdings |
| Richard Balla | Chief Executive Officer of Adjupharm |
| Oren Shuster | Chief Executive Officer and Executive Director |
| Asi Levi | Chief Financial Officer |
| Anna Taranko | Director Investor and Public Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 13, 2026 | 6-K | Report of foreign issuer |
| Nov 13, 2026 | SCHEDULE 13G/A | Filing |
| Nov 13, 2026 | SCHEDULE 13G/A | Filing |
| Nov 13, 2026 | SCHEDULE 13G/A | Filing |
| Nov 10, 2026 | F-3 | Filing |
| Nov 4, 2026 | 6-K | Report of foreign issuer |
| Oct 20, 2026 | EFFECT | Notice of Effectiveness |
| Oct 8, 2026 | F-3 | Filing |
| Oct 2, 2026 | 6-K | Report of foreign issuer |
| Sep 30, 2026 | SCHEDULE 13G | Filing |